WorldQuant Millennium Advisors
NVAX icon

WorldQuant Millennium Advisors’s Novavax NVAX Stock Holding History

WorldQuant Millennium Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-142,745
Closed -$7.34M – 359
2022
Q2 		$7.34M Buy
142,745
+107,853
+309% +$5.59M 0.21% 145
2022
Q1 		$2.57M Buy
+34,892
New +$3.11M 0.06% 239
2021
Q4 		– Sell
-112,069
Closed -$23.2M – 364
2021
Q3 		$23.2M Buy
112,069
+64,501
+136% +$14.2M 0.51% 53
2021
Q2 		$10.1M Buy
+47,568
New +$8.72M 0.22% 133

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

WorldQuant Millennium Advisors's NVAX Position: Q3 2022 in Review

WorldQuant Millennium Advisors sold out of Novavax (NVAX) in Q3 2022, closing a stake of 142,745 shares — an estimated $7.34M sold.

WorldQuant Millennium Advisors first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $23.2M in Q3 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • WorldQuant Millennium Advisors reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 142,745 Novavax shares in Q3 2022, an estimated $7.34M.
  • WorldQuant Millennium Advisors first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
  • WorldQuant Millennium Advisors's Novavax position peaked at $23.2M in Q3 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on WorldQuant Millennium Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.